You are now leaving the Lundbeck Canada website

Links to sites outside of Lundbeck Canada are provided as resources to visitors and may not reflect Canada regulation or prescribing information. Lundbeck Canada accepts no responsibility for the content of linked sites.

Click here to proceed



Media Relations

Lundbeck seeks an open and active dialogue with the press. Members of the press are always welcome to direct enquiries to our press contacts who work to handle them quickly and professionally.

Members of the Media seeking further information may contact:

About Lundbeck

Lundbeck is a global biopharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research. We are tirelessly dedicated to restoring brain health, so every person can be their best.


Millions of people worldwide live with brain diseases, and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement, and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with brain diseases.


Our approximately 5,600 employees in more than 50 countries are engaged in the entire value chain throughout research, development, production, marketing, and sales. Our pipeline consists of several R&D programs, and our products are available in more than 100 countries. We have research centers in Denmark and the US, and our production facilities are located in Denmark, France, and Italy. Lundbeck generated revenue of DKK 17.7 billion in 2020 (EUR 2.4 billion; USD 2.7 billion).


For additional information, we encourage you to connect with us on Twitter at @Lundbeck and via LinkedIn.

Global Media Library

Pictures of our Executive Management, videos, and other assets for download and distribution.


70 years

In front of neuroscience research


Countries of operation around the world


Employees worldwide

17.7 b DKK

Of revenue generated in 2020